Alliance Pharma plc
APH
Delayed London Stock Exchange - 11/21 05:35:14 pm
59GBp
-0.21%
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Sales97,5104
EBITDA26,028,4
Operating profit (EBIT)25,627,7
Pre-Tax Profit (EBT)22,226,2
Net income18,121,8
EPS (GBp )3,824,87
Dividend per Share (GBp )1,211,29
Yield2,55%2,19%
Announcement Date03/29/2017
07:29am
-
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 20162017
Debt76,159,8
Finance--
Operating income (EBITDA)26,028,4
Leverage
(Debt/EBITDA)
2,92x2,10x
Capital Expenditure1,132,35
Book Value Per Share (BVPS)--
Cash Flow per Share--
Announcement Date03/29/2017
07:29am
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 280 M GBP -
Entreprise Value (EV) 340 M GBP 325 M GBP
Valuation 2017e 2018e
P/E ratio (Price / EPS) 12,1x 13,5x
Capitalization / Revenue 2,71x 2,55x
EV / Revenue 3,29x 2,96x
EV / EBITDA 12,0x 10,4x
Yield (DPS / Price) 2,19% 2,43%
Price to book (Price / BVPS) - -
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 26,8% 27,1%
operating Leverage (Delta EBIT / Delta Sales) 1,31x 1,20x
Net Margin (Net Profit / Revenue) 21,0% 18,9%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) 10,7% 9,85%
Rate of Dividend 26,6% 32,9%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   2,27% 1,67%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 2,10x 1,43x
Price Earning Ratio
BNA & Dividende